| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,314 |
2,012 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
316 |
258 |
$24K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
294 |
271 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
261 |
252 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
470 |
405 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
120 |
104 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
88 |
71 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
84 |
84 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
82 |
80 |
$6K |
| 90686 |
|
194 |
181 |
$1K |
| 96127 |
|
79 |
64 |
$1K |
| 90670 |
|
89 |
78 |
$984.58 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
63 |
59 |
$746.46 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
20 |
17 |
$508.98 |
| D1206 |
Topical application of fluoride varnish |
14 |
14 |
$390.00 |
| 90647 |
|
26 |
14 |
$298.28 |
| 90723 |
|
12 |
12 |
$76.80 |